Beneficial effects of consumption of a dairy product containing two probiotic strains, Lactobacillus coryniformis CECT5711 and Lactobacillus gasseri CECT5714 in healthy children;Efectos beneficiosos en niños sanos del consumo de un producto lácteo que contiene dos cepas probióticas. Lactobacillus coryniformis CECT5711 y Lactobacillus gasseri CECT5714

Nutricion Hospitalaria

Volumn 22, Issue 4, 2007, Pages 496-502

  Lara Villoslada, F ^a   Sierra, S ^a   Boza, J ^a   Xaus, J ^a   Olivares, M ^a  

^a Puleva Biotech   (Spain)

Author keywords

Gastrointestinal tract; Inmune system; Probiotics

Indexed keywords

IMMUNOGLOBULIN A; MUCIN; PROBIOTIC AGENT; WATER; YOGHURT;

ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIUM ADHERENCE; CHILD; COMPARATIVE STUDY; CYTOTOXICITY; DAIRY PRODUCT; DIET; FECES; FEMALE; FOOD INTAKE; GASTROINTESTINAL INFECTION; HUMAN; IMMUNE SYSTEM; INTESTINE FLORA; LACTOBACILLUS BULGARICUS; LACTOBACILLUS CORYNIFORMIS; LACTOBACILLUS GASSERI; MALE; SALIVA; SALMONELLA CHOLERASUSIS; SAMPLING; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS THERMOPHILUS;

BACTERIAL ADHESION; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; DISEASE SUSCEPTIBILITY; FECES; FEMALE; GASTROENTERITIS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; INTESTINES; LACTOBACILLUS; MALE; MUCINS; PROBIOTICS; SALIVA; SALMONELLA; SPAIN; SPECIES SPECIFICITY; STREPTOCOCCUS THERMOPHILUS; YOGURT;

LACTOBACILLUS CORYNIFORMIS; LACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS; LACTOBACILLUS GASSERI; SALMONELLA; STREPTOCOCCUS THERMOPHILUS;

EID: 34548315893     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Holzapfel WH, Hebrer P, Snel J y cols. Overview of gut flora and probiotics. Int J Food Microbiol 1998; 41:85-101.
2. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2002; 360:512-19.
3. Schrezenmeir J, De Vrese M. Probiotics, prebiotics and symbiotics: approaching a definition. Am J Clin Nutr 2001; 73 (2 Supl.):421S-429S.
4. Marteau P, Seksik P, Jian R. Probiotic and intestinal health effects: a clinical perspective. Br J Nutr 2002: 88(Supl. 1):S51-57.
5. Saavedra JM, Bauman NA, Oung I y cols. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 1994; 344:1046-1049.
6. Szajewska H, Kotowska M, Mruckovicz JZ y cols. Efficacy of Lactobacillus GG in prevention of nosocomial diarrea in infants. J Pediatr 2001; 138:361-365.
7. Kruis W, Schutz E, Fric P y cols. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997; 11:853-858.
8. Schiffrin EJ, Rochar F, Link-Amster H y cols. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 1995; 78:491-497.
9. Link-Hamster H, Rochat F, Saudan KY y cols. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 1994; 10:55-64.
10. Martín R, Langa S, Reviriego C y cols. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr 2003; 143(6):754-758.
11. Olivares M, Díaz-Ropero MP, Gómez N y cols. Oral administration of two probiotic strains, Lactobacillus coryniformis CECT5711 and Lactobacillus gasseri CECT5714, enhances the intestinal function of healthy adults. Int J Food Microbiol 2006; 107:104-111.
12. Olivares M, Díaz-Ropero MP, Gómez N y cols. The consumption of two probiotic strains, Lactobacillus coryniformis CECT5711 and Lactobacillus gasseri CECT5714, boost the immune system of healthy humans. Int Microbiol 2006; 9:47-52.
13. Rodríguez-Cabezas ME, Gálvez J, Lorente MD y cols. Dietary fiber down- regulates colonia tumor necrosis factor alpha and nitric oxide production in TNBS-induced colitic rats. J Nutr 2002; 132(11):3263-3271.
14. Xaus J, Comalada M, Valledor A y cols. Decorin inhibits macrophage colony- stimulating factor proliferation of macropahges and enhances cell survival through induction of p27 (Kip1) and p21 (Waf1). Blood 2001; 98(7):2124-2133.
15. Cohen PS, Laux DC. Bacterial adhesion to and penetration of intestinal mucus in vitro. Methods Enzymol 1995; 253:309-14.
16. Gill HS, Guarner F. Probiotics and human health: a clinical perspective. Pstgrad Med J 2004; 80:516-526.
17. Wollowski I, Rechkemmer G, Pool-Zobel BL. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 2001; 73(2 Supl.):451S-455S.
18. Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003; 52:988-997.
19. Granato D, Bergonzelli GE, Pridmore RD y cols. Cell surface-associated elongation factor TU mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucin. Infect Immun 2004; 72:2160-2169.
20. Sakata T, Kojima T, Fujieda M, Takahashi M, Michibata T. Influences of probiotic bacteria on organic acid production by pig caecal bacteria in vitro. Proc Nutr Soc 2003; 62(1):73-80.
21. Gibson GR, McCartney AL, Rastall RA. Prebiotics and resistance to gastrointestinal infections. Br J Nutr 2005; 93(Supl. 1): S31-34.
22. Saxelin M, Tynkkynen S, Mattila-Sandholm T, De Vos WM. Probiotic and other functional microbes: from markets to mechanisms. Curr Opin Biotechnol 2005; 16(2):204-211.